Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of TA-8995 in Patients With Mild Dyslipidaemia, Alone and In Combination With Statin Therapy

NCT01970215 is registered in ClinicalTrials.gov with Xention Ltd as lead sponsor.

NCT NCT01970215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01970215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of TA-8995 in Patients With Mild Dyslipidaemia, Alone and In Combination With Statin Therapy
Lead sponsor
Xention Ltd
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2013
Completion date
July 31, 2014
Enrollment
364 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia